Apoptosis of CD19+ chimeric antigen receptor T cells after treatment with chemotherapeutic agents

Molecular Medicine Reports
Wenfang YiChunfu Li

Abstract

The use of chemotherapeutic agents prior to treatment with infusion of cluster of differentiation (CD)19-chimeric antigen receptor (CAR)‑T cells is important for the efficacy of clinical therapies against hematological malignancies. However, the effect of chemotherapeutic agents on CD19‑CAR‑T cells and the associated underlying mechanisms remain unknown. The first aim of the present study was to determine the effect of chemotherapeutic agents on CAR‑T cells using the in vitro Cell Counting kit 8 assay. The second aim was to evaluate the abilities of fludarabine (FDR) and mafosfamide (MFA; a metabolite of cyclophosphamide) to induce apoptosis of CD19‑CAR‑T cells via the use of Annexin V/propidium iodide double staining. In addition, a JC‑1 fluorescent probe was used to detect alterations in cell membrane potential, and flow cytometry analysis was used to measure concentrations of caspase‑3/7 to identify apoptotic pathways of CD19‑CAR‑T cells. The data of the present study suggested that FDR and MFA inhibit the activities of CD19‑CAR‑T cells. Alterations to the mitochondrial membrane potential and an increase in the concentration of caspase‑3/7 indicated early apoptosis of FDR‑ and MFA‑treated CD19‑CAR‑T cells. The present study ...Continue Reading

References

Jun 18, 1993·Journal of Immunological Methods·J A Smith, M J Weidemann
Jun 21, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·M AlemánM C Sasiain
Jan 8, 2003·The Journal of Experimental Medicine·Kevin J MaloyFiona Powrie
Nov 10, 2005·Arthritis Research & Therapy·Haidi ZhangH Ralph Schumacher
Apr 4, 2006·Current Opinion in Rheumatology·Joanna StanczykSteffen Gay
Sep 16, 2010·TheScientificWorldJournal·Driss El Kebir, János G Filep
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
Jan 9, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Drew C DenigerLaurence J N Cooper
Mar 27, 2013·The New England Journal of Medicine·Stephan A GruppCarl H June
Apr 9, 2013·Hematology/oncology Clinics of North America·Marco L Davila, Renier Brentjens
Jun 22, 2013·Leukemia Research·Joshua Lukenbill, Matt Kalaycio
Nov 15, 2013·Science Translational Medicine·Christopher G KanakryLeo Luznik

❮ Previous
Next ❯

Methods Mentioned

BETA
flow
flow cytometry
Assay

Software Mentioned

SPSS
WinMDI
C6 Plus

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.